These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 25643053)

  • 21. Outcome reliability in non-ambulatory boys/men with Duchenne muscular dystrophy.
    Connolly AM; Malkus EC; Mendell JR; Flanigan KM; Miller JP; Schierbecker JR; Siener CA; Golumbek PT; Zaidman CM; Mcdonald CM; Johnson L; Nicorici A; Karachunski PI; Day JW; Kelecic JM; Lowes LP; Alfano LN; Darras BT; Kang PB; Quigley J; Pasternak AE; Florence JM;
    Muscle Nerve; 2015 Apr; 51(4):522-32. PubMed ID: 25056178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
    Manzur AY; Kuntzer T; Pike M; Swan A
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of hand grip strength with functional measures in non-ambulatory children with Duchenne muscular dystrophy.
    Bulut N; Gürbüz I; Yilmaz Ö; Aydin G; Karaduman A
    Arq Neuropsiquiatr; 2019 Nov; 77(11):792-796. PubMed ID: 31826135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase 2 open-label study of the safety and efficacy of weekly dosing of ATL1102 in patients with non-ambulatory Duchenne muscular dystrophy and pharmacology in mdx mice.
    Woodcock IR; Tachas G; Desem N; Houweling PJ; Kean M; Emmanuel J; Kennedy R; Carroll K; de Valle K; Adams J; Lamandé SR; Coles C; Tiong C; Burton M; Villano D; Button P; Hogrel JY; Catling-Seyffer S; Ryan MM; Delatycki MB; Yiu EM
    PLoS One; 2024; 19(1):e0294847. PubMed ID: 38271438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quadriceps muscle strength in Duchenne muscular dystrophy and effect of corticosteroid treatment.
    Merlini L; Cecconi I; Parmeggiani A; Cordelli DM; Dormi A
    Acta Myol; 2020 Dec; 39(4):200-206. PubMed ID: 33458575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knee Strength and Ankle Range of Motion Impacts on Timed Function Tests in Duchenne Muscular Dystrophy: In the Era of Glucocorticoids.
    Duong T; Canbek J; Fernandez-Fernandez A; Henricson E; Birkmeier M; Siener C; Tesi Rocha C; McDonald C; Gordish-Dressman H;
    J Neuromuscul Dis; 2022; 9(1):147-159. PubMed ID: 34719507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Association between the Respiratory System and Upper Limb Strength in Males with Duchenne Muscular Dystrophy: A New Field for Intervention?
    Sobierajska-Rek A; Wasilewska E; Śledzińska K; Jabłońska-Brudło J; Małgorzewicz S; Wasilewski A; Szalewska D
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
    Manzur AY; Kuntzer T; Pike M; Swan A
    Cochrane Database Syst Rev; 2004; (2):CD003725. PubMed ID: 15106215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional trajectories before and after loss of ambulation in Duchenne muscular dystrophy and implications for clinical trials.
    McDonald CM; Signorovitch J; Mercuri E; Niks EH; Wong B; Fillbrunn M; Sajeev G; Yim E; Dieye I; Miller D; Ward SJ; Goemans N;
    PLoS One; 2024; 19(6):e0304099. PubMed ID: 38829874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Test-retest reliability of the Performance of Upper Limb (PUL) module for muscular dystrophy patients.
    Gandolla M; Antonietti A; Longatelli V; Biffi E; Diella E; Delle Fave M; Rossini M; Molteni F; D'Angelo G; Bocciolone M; Pedrocchi A
    PLoS One; 2020; 15(9):e0239064. PubMed ID: 32986757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring daily physical activity of upper extremity in young and adolescent boys with Duchenne muscular dystrophy: A pilot study.
    van der Geest A; Essers JMN; Bergsma A; Jansen M; de Groot IJM
    Muscle Nerve; 2020 Mar; 61(3):293-300. PubMed ID: 31742708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study.
    Coratti G; Pane M; Brogna C; D'Amico A; Pegoraro E; Bello L; Sansone VA; Albamonte E; Ferraroli E; Mazzone ES; Fanelli L; Messina S; Sframeli M; Catteruccia M; Cicala G; Capasso A; Ricci M; Frosini S; De Luca G; Rolle E; De Sanctis R; Forcina N; Norcia G; Passamano L; Scutifero M; Gardani A; Pini A; Monaco G; D'Angelo MG; Leone D; Zanin R; Vita GL; Panicucci C; Bruno C; Mongini T; Ricci F; Berardinelli A; Battini R; Masson R; Baranello G; Dosi C; Bertini E; Nigro V; Politano L; Mercuri E
    Neuromuscul Disord; 2024 Jan; 34():75-82. PubMed ID: 38157655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural history of Type 2 and 3 spinal muscular atrophy: 2-year NatHis-SMA study.
    Annoussamy M; Seferian AM; Daron A; Péréon Y; Cances C; Vuillerot C; De Waele L; Laugel V; Schara U; Gidaro T; Lilien C; Hogrel JY; Carlier P; Fournier E; Lowes L; Gorni K; Ly-Le Moal M; Hellbach N; Seabrook T; Czech C; Hermosilla R; Servais L;
    Ann Clin Transl Neurol; 2021 Feb; 8(2):359-373. PubMed ID: 33369268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different types of upper extremity exercise training in Duchenne muscular dystrophy: effects on functional performance, strength, endurance, and ambulation.
    Alemdaroğlu I; Karaduman A; Yilmaz ÖT; Topaloğlu H
    Muscle Nerve; 2015 May; 51(5):697-705. PubMed ID: 25196721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial.
    Hafner P; Bonati U; Rubino D; Gocheva V; Zumbrunn T; Gueven N; Fischer D
    Trials; 2016 Aug; 17(1):389. PubMed ID: 27488051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Duchenne muscular dystrophy with ciclosporin A: a randomised, double-blind, placebo-controlled multicentre trial.
    Kirschner J; Schessl J; Schara U; Reitter B; Stettner GM; Hobbiebrunken E; Wilichowski E; Bernert G; Weiss S; Stehling F; Wiegand G; Müller-Felber W; Thiele S; Grieben U; von der Hagen M; Lütschg J; Schmoor C; Ihorst G; Korinthenberg R
    Lancet Neurol; 2010 Nov; 9(11):1053-9. PubMed ID: 20801085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Duchenne Muscular Dystrophy: Safety and Feasibility Study in India.
    Rajput BS; Chakrabarti SK; Dongare VS; Ramirez CM; Deb KD
    J Stem Cells; 2015; 10(2):141-56. PubMed ID: 27125141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of long-term steroids on cough efficiency and respiratory muscle strength in patients with Duchenne muscular dystrophy.
    Daftary AS; Crisanti M; Kalra M; Wong B; Amin R
    Pediatrics; 2007 Feb; 119(2):e320-4. PubMed ID: 17272595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial.
    Nagy S; Hafner P; Schmidt S; Rubino-Nacht D; Schädelin S; Bieri O; Fischer D
    Trials; 2019 Nov; 20(1):637. PubMed ID: 31752977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy.
    Connolly AM; Schierbecker J; Renna R; Florence J
    Neuromuscul Disord; 2002 Dec; 12(10):917-25. PubMed ID: 12467746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.